Volumetric erythrocyte macrocytosis induced by hydroxyurea

Area of Science:

• Hematology
• Red Blood Cell Morphology
• Drug-Induced Effects

Background:

• Macrocytosis is typically associated with megaloblastic anemia or pseudomacrocytes due to viscoelastic defects.
• Understanding different forms of macrocytosis is crucial for accurate diagnosis and patient management.

Purpose of the Study:

• To describe a distinct form of macrocytosis, termed volumetric macrocytosis.
• To differentiate volumetric macrocytosis from other types of macrocytes.
• To investigate the characteristics and potential causes of volumetric macrocytosis.

Main Methods:

• Morphological analysis of red blood cells.
• Measurement of mean corpuscular volume (MCV) and cell diameter.
• Assessment of red blood cell hydration and hemoglobin content.

Main Results:

• Volumetric macrocytosis is characterized by increased mean corpuscular volume with normal cell diameter.
• These macrocytes are thicker, overhydrated, and contain more hemoglobin than normocytic red blood cells.
• Volumetric macrocytosis shares features with neonatal red blood cells.
• This condition is observed during sustained hydroxyurea therapy.

Conclusions:

• Volumetric macrocytosis represents an atypical form of macrocytosis.
• It may be a manifestation of drug-induced dyserythropoiesis, specifically associated with hydroxyurea.
• Further research is needed to fully elucidate the mechanisms and clinical implications of volumetric macrocytosis.